Getting to Cures: The Next Five Years in Immunotherapy, with Jedd Wolchok

On June 25, 2015, Jedd D. Wolchok, M.D., Ph.D, discussed the current advances in cancer immunotherapy and where he sees us going in the next five years.

Dr. Wolchok is chief of the Melanoma and Immunotherapeutics Service at Memorial Sloan Kettering Cancer Center (MSKCC); an associate director of the Ludwig Center for Cancer Immunotherapy at MSKCC, an associate member of Ludwig Cancer Research, and the Lloyd J. Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation at MSKCC. He is director of the CRI/Ludwig clinical trials network, and is an associate director of the CRI Scientific Advisory Council. He is also the co-director of the Swim Across America laboratory at MSKCC, one of the foremost immunotherapy and melanoma research groups in the country.

[fareedaali]

u tube gives us a knowledge to every field of life thank you for u tube